0 citations
Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism
Cerebrovascular Diseases2020Vol. 49(6), pp. 601–608
Citations Over Time
Noriko Sato, Ryu Matsuo, Fumi Kiyuna, Kuniyuki Nakamura, Jun Hata, Yoshinobu Wakisaka, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, collab on behalf of the Fukuoka Stroke Registry Investigators
Abstract
This nonrandomized observational study suggests that anticoagulation therapy might be associated with a reduced risk of recurrent stroke compared with antiplatelet therapy in patients with ESUS in whom no potential source of embolism was identified. Further study should be performed in consideration of a potential source of embolism even in patients with ESUS.
Related Papers
- → Aortic valve papillary fibroelastoma causing embolic strokes: a case report and review(2017)7 cited
- → Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation(2007)10 cited
- → Non stenotic carotid plaque and embolic stroke from undeterminated source (ESUS): Is there a link ?(2019)
- → The correlation of embolic sources with infarct pattern in patients with embolic stroke (P6-5.015)(2023)
- → Supplementary Material for: Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism(2020)